Covid-19: what you need to know about the vaccines used in France and the vaccination schedule

► Pfizer-BioNTech (USA / ALL)
Aurelien Morissard / IP3 PRESS / MAXPPP
Vaccine type : to ARN Messager
Administration : 2 injections 21 days apart
Conservation : if the bottle is not opened, up to 6 months between -90 ° and -60 ° C, after opening up to 5 days between 2 ° and 8 ° C
Efficiency : around 94.6%
Reduction of virus transmission : unknown
Date of validation by the European Medicines Agency (EMA) : December 21, 2020
Number of doses ordered by the European Union : 400 million, with an option for an additional 100 million
Number of doses already delivered in France (as of April 25, 2021): 15,134,090
► Moderna (USA)
Fotostand / K. Schmitt / picture alliance / Fotostand
Vaccine type : to ARN Messager
Administration : 2 injections 28 days apart
Conservation : if the bottle is not opened, up to 7 months at between -25 ° and -15 ° C or up to 30 days in the refrigerator; after opening, up to 12 hours between 8 ° and 25 ° C
Efficiency : around 94.5%
Reduction of virus transmission : unknown
Validation date by the AEM : January 6, 2021
Number of doses ordered by the European Union : 310 million, with an option for an additional 150 million
Number of doses already delivered in France (as of April 25, 2021): 1,902,600
► AstraZeneca (SUE / GBR)
Pavlo Gonchar / ZUMA PRESS / MAXPPP / MAXPPP
Vaccine type : viral vector (chimpanzee adenovirus)
Administration : 2 injections, with 9 to 12 weeks interval between the two
⇒ On March 19, the French National Authority for Health recommends reserving this vaccine for people aged 55 and over
Conservation : if the bottle is not opened, up to 6 months between 2 ° and 8 ° C; after opening up to 48 hours in the refrigerator
Efficiency : between 62% and 90%
Reduction of virus transmission : up to 67% (preliminary studies)
Validation date by the AEM : January 29, 2021
Number of doses ordered by the European Union : 300 million
Number of doses already delivered in France (as of April 25, 2021): 5,105,400
► Johnson & Johnson (USA), also called Janssen in Europe
Arnaud Journois / PHOTOPQR / LE PARISIEN / MAXPPP
Vaccine type : viral vector (adenovirus 26)
Administration : 1 injection
Conservation : if the bottle is not opened, up to 2 years between -25 ° and -15 ° C; after opening up to 3 months between 2 ° and 8 ° and in the dark
Efficiency : around 66%, up to 85% against severe forms
Reduction of virus transmission : unknown
Validation date by the AEM : March 11, 2021
Number of doses ordered by the European Union : 200 million, with an option for an additional 200 million
Number of doses already delivered in France (as of April 25, 2021): 206,400
————
Vaccination schedule
The vaccination schedule / Visactu
♦ People who can currently be vaccinated in France
⇒ All people aged 55 and over regardless of where they live and their state of health (with or without co-morbidities)
⇒ The pregnant women from the second trimester of pregnancy
⇒ The residents in residential facilities for the elderly dependent and long-term care units or housed in independent residences and assisted living facilities
⇒ People from over 18 suffering from a very high risk pathology of severe form of Covid-19 (list via the link below)
⇒ The people aged 50 to 54 inclusive suffering from one or more of the comorbidities
⇒ The people with disabilities, whatever their age, hosted in specialized reception homes (MAS) and nursing homes (FAM)
⇒ The residents aged 60 and over in migrant worker hostels (FTM)
⇒ The professionals in the health sector and the medico-social sector belonging to certain categories
► Everything you need to know about the list of comorbidities and that of priority audiences
.